New York State Common Retirement Fund’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,600
Closed -$157K 3244
2019
Q3
$157K Hold
5,600
﹤0.01% 2879
2019
Q2
$79K Sell
5,600
-7,500
-57% -$71.3K ﹤0.01% 3163
2019
Q1
$116K Hold
13,100
﹤0.01% 2919
2018
Q4
$99K Hold
13,100
﹤0.01% 2966
2018
Q3
$275K Hold
13,100
﹤0.01% 2691
2018
Q2
$392K Buy
13,100
+7,200
+122% +$196K ﹤0.01% 2557
2018
Q1
$160K Hold
5,900
﹤0.01% 2826
2017
Q4
$170K Buy
5,900
+4,500
+321% +$123K ﹤0.01% 2828
2017
Q3
$34K Buy
+1,400
New +$33.2K ﹤0.01% 3075

New York State Common Retirement Fund's DOVA Position: Q4 2019 in Review

New York State Common Retirement Fund sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 5,600 shares — an estimated $157K sold.

New York State Common Retirement Fund first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $392K in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • New York State Common Retirement Fund reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • New York State Common Retirement Fund sold 5,600 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $157K.
  • New York State Common Retirement Fund first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • New York State Common Retirement Fund's Dova Pharmaceuticals, Inc. Common Stock position peaked at $392K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.